Active	Status	Sponsor type	Region	Phase	Filter
2 Active 3 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
niclosamide (DWRX2003) / Daewoong Pharma
NCT04524052: To Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of DWRX2003 Against COVID-19	Not yet recruiting	1	32	NA	DWRX2003, Placebo	Daewoong Pharmaceutical Co. LTD.	Healthy	12/20	12/20
NCT04592835: To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003	Not yet recruiting	1	24	NA	DWRX2003	Daewoong Pharmaceutical Co. LTD., Novotech (Australia) Pty Limited	COVID-19 Patients	12/20	06/21